According to the new report entitled, Global Neuromodulation Market accounted to USD 4.05billion in 2016 growing at a CAGR of 12.22% during the forecast period of 2017 to 2024. Market segmented By Technology (Internal Neuromodulation, External Neuromodulation), By Application (SCS, DBS, Sacral, Vagus, Gastric Electrical, Transcutaneous Electrical, Repetitive Transcranial Magnetic, Respiratory Electrical), By Geography – Industry Trends and Forecast to 2024

Pune, India -- (SBWire) -- 01/15/2018 --Global Neuromodulation Market added by Data Bridge Market Research, report delivers a strategic analysis and growth forecast for the period from 2017 – 2024. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of technology and application. It also covers geographical analysis of the market with growth forecast for the period of 2017 – 2024

Years considered for this report:


- Historical Year: 2015

- Base Year: 2016

- Estimated Year: 2017

- Forecast Period: 2017–2024


Request for Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-neuromodulation-market

Top Competitors of Global Neuromodulation Market

- BioAlps Association,

- Bioness Inc.,

- Soterix Medical Inc.,

- Medtronic,

- Abbott,

- Boston Scientific Corporation,

- LivaNova PLC,

- Axonics Modulation Technologies, Inc.,

- Johnson & Johnson Services Inc.,

- DynaMD,

- BioControl Medical,

- Synapse Biomedical Inc.

- Among Others

Request for Table of Content and Figures@: http://databridgemarketresearch.com/toc/?dbmr=global-neuromodulation-market

Global Neuromodulation Market Segmentation
The neuromodulation market is segmented by technology into internal neuromodulation and external neuromodulation (Non-invasive). Internal Neuromodulation is sub segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS) and gastric electrical stimulation (GES).External neuromodulation (non-invasive) is sub segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS) and respiratory electrical stimulation (RES).

On the basis of application the market is segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation market, vagus nerve stimulation market, gastric electrical stimulation market, transcutaneous electrical nerve stimulation market, repetitive transcranial magnetic stimulation market and respiratory electrical stimulation market.

Spinal cord stimulation (SCS) market is further sub segmented by application into failed back syndrome (FBSS), chronic pain and ischemia. Deep brain stimulation (DBS) market is further sub segmented by application into Parkinson's disease, tremor and depression. Sacral Nerve Stimulation Market is further sub segmented by application into urine incontinence and fecal in continence. Vagus Nerve Stimulation Market is further sub segmented by application into epilepsy and others. Gastric electrical stimulation market is further sub segmented by application into gastroparesis and obesity. Transcutaneous electrical nerve stimulation market is further sub segmented by application into treatment resistant depression and others. Repetitive transcranial magnetic stimulation market is further sub segmented by application into depression and migraine headache. Respiratory electrical stimulation market is further sub segmented by application into spinal cord injury.

On the basis of geography, neuromodulation market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Key Drivers:


- Rise in geriatric population

- Increase in cases of neurological diseases such as Alzheimer's and Parkinson's diseases

- Increase in awareness regarding the safety and efficacy of neurostimulator devices

- Robust product pipeline

- Rise in investments and funds

- Unfavorable reimbursement policies

- Lack of healthcare professionals


Purchase Full Report of Global Neuromodulation Market @: http://databridgemarketresearch.com/reports/global-neuromodulation-market/

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) –  Industry Trends and Forecast to 2024

Report:  http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research